• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Teva Pharmaceutical Industries Limited (TEVA)

    -NYSE
    58.00 1.35(2.38%) Dec 19, 4:09PM EST
    |Pre-Market : 58.52 Up 0.52 (0.90%) 5:28AM EST
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.1
    Mean Recommendation (last week):2.2
    Change:-0.1

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:63.83
    Median Target:64.50
    High Target:70.00
    Low Target:55.00
    No. of Brokers:24

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Oct 14, 2014Standpoint ResearchUpgradeHoldBuy
    Oct 2, 2014Standpoint ResearchDowngradeBuyHold
    Jun 27, 2014Canaccord GenuityInitiated Hold
    Jun 6, 2014ArgusUpgradeHoldBuy
    Apr 7, 2014National Alliance SecuritiesInitiated Buy
    Mar 7, 2014BarclaysUpgradeEqual WeightOverweight
    Jan 7, 2014RBC Capital MktsInitiated Sector Perform
    Jun 19, 2013Maxim GroupInitiated Buy
    Feb 25, 2013ArgusDowngradeBuyHold
    May 23, 2012AurigaInitiated Hold

    More Upgrades & Downgrades for TEVA

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0777
    Buy0788
    Hold0131414
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.